Literature DB >> 31143517

Interaction of tumor-associated macrophages and cancer chemotherapy.

Irina Larionova1,2, Nadezhda Cherdyntseva1,2, Tengfei Liu3, Marina Patysheva2, Militsa Rakina1, Julia Kzhyshkowska1,3,4.   

Abstract

It has been recently recognized that the tumor microenvironment (TME) is an essential factor that defines the efficiency of chemotherapy. The local TME, consisting of immune cells with diverse phenotypes and functions, can strongly modulate the response to chemotherapy. Tumor-associated macrophages (TAMs) that display pronounced heterogeneity and phenotypic plasticity are the major innate immune component in the microenvironment of solid tumors. In our review, we elucidate the complex role of TAMs in the progression of different types of solid tumors, summarize the current knowledge about the effects of different anticancer chemotherapeutic agents on monocytes/macrophages, and describe the mechanisms of chemotherapy resistance mediated by TAMs.

Entities:  

Keywords:  Tumor-associated macrophages; cancer chemotherapy; chemoresistance; immune system; immunomodulation; tumor progression

Year:  2019        PMID: 31143517      PMCID: PMC6527283          DOI: 10.1080/2162402X.2019.1596004

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  118 in total

Review 1.  Therapeutic monoclonal antibodies.

Authors:  F C Breedveld
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

Review 2.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.

Authors:  Christina Cintin; Julia S Johansen; Ib Jarle Christensen; Paul A Price; Steen Sørensen; Hans Jørgen Nielsen
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

Review 4.  Multiple roles for cysteine cathepsins in cancer.

Authors:  Johanna A Joyce; Douglas Hanahan
Journal:  Cell Cycle       Date:  2004-12-06       Impact factor: 4.534

5.  Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.

Authors:  T Mäkitie; P Summanen; A Tarkkanen; T Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

6.  YKL-39 (chitinase 3-like protein 2), but not YKL-40 (chitinase 3-like protein 1), is up regulated in osteoarthritic chondrocytes.

Authors:  T Knorr; F Obermayr; E Bartnik; A Zien; T Aigner
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

7.  Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.

Authors:  Jeremy J W Chen; Pei-Li Yao; Ang Yuan; Tse-Ming Hong; Chia-Tung Shun; Min-Liang Kuo; Yung-Chie Lee; Pan-Chyr Yang
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

8.  Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.

Authors:  Seyedhossein Aharinejad; Patrick Paulus; Mouldy Sioud; Michael Hofmann; Karin Zins; Romana Schäfer; E Richard Stanley; Dietmar Abraham
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

Review 9.  Cathepsin B and its role(s) in cancer progression.

Authors:  Izabela Podgorski; Bonnie F Sloane
Journal:  Biochem Soc Symp       Date:  2003

10.  High serum YKL-40 level in patients with small cell lung cancer is related to early death.

Authors:  Julia S Johansen; Lars Drivsholm; Paul A Price; Ib Jarle Christensen
Journal:  Lung Cancer       Date:  2004-12       Impact factor: 5.705

View more
  70 in total

Review 1.  Tackling TAMs for Cancer Immunotherapy: It's Nano Time.

Authors:  Yishun Yang; Jianfeng Guo; Leaf Huang
Journal:  Trends Pharmacol Sci       Date:  2020-10       Impact factor: 14.819

Review 2.  Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review).

Authors:  Olga V Zhukova; Tatiana F Kovaleva; Evgenia V Arkhipova; Sergey A Ryabov; Irina V Mukhina
Journal:  Biomed Rep       Date:  2020-08-28

Review 3.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

Review 4.  Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation.

Authors:  K Laxmi Swetha; Kavya Sree Maravajjala; Shyh-Dar Li; Manu Smriti Singh; Aniruddha Roy
Journal:  Drug Deliv Transl Res       Date:  2022-06-13       Impact factor: 4.617

Review 5.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

Review 6.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

7.  Exosomal miR-487a derived from m2 macrophage promotes the progression of gastric cancer.

Authors:  Xuefeng Yang; Shuang Cai; Yue Shu; Xun Deng; Yuanwei Zhang; Nian He; Lei Wan; Xu Chen; Yan Qu; Shouyang Yu
Journal:  Cell Cycle       Date:  2021-01-31       Impact factor: 4.534

Review 8.  Tumor microenvironment as a therapeutic target in cancer.

Authors:  Yi Xiao; Dihua Yu
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

Review 9.  Tumor immune microenvironment in head and neck cancers.

Authors:  Samantha M Y Chen; Alexandra L Krinsky; Rachel A Woolaver; Xiaoguang Wang; Zhangguo Chen; Jing H Wang
Journal:  Mol Carcinog       Date:  2020-02-03       Impact factor: 4.784

10.  Pro-tumoral functions of tumor-associated macrophage EV-miRNA.

Authors:  Alexander Cocks; Filippo Del Vecchio; Verena Martinez-Rodriguez; Monique Schukking; Muller Fabbri
Journal:  Semin Cancer Biol       Date:  2021-08-08       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.